DANNA GARCIA-GUAQUETA

Dr. DANNA GARCIA-GUAQUETA

Universidad del Rosario, Bogotá-Colombia
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 October 2021 in Nutrients
Verified
Journal Article
Open access
PDF file
MCMaría Camila Cortés-Albornoz
María Camila Cortés-Albornoz
DANNA GARCIA-GUAQUETADANNA GARCIA-GUAQUETA
DANNA GARCIA-GUAQUETA
AMAlberto Francisco Vélez Van Meerbeke
Alberto Francisco Vélez Van Meerbeke
CTClaudia Talero-Gutierrez
Claudia Talero-Gutierrez
In this scoping review, we examined the association between maternal nutrition during pregnancy and neurodevelopment in offspring. We searched the Pubmed and ScienceDirect databases for articles published from 2000 to 2020 on inadequate intake of vitamins (B12, folate, vitamin D, vitamin A, vitamin E, vitamin K), micronutrients (cooper, iron, creatine, choline, zinc, iodine), macronutrients (fatty acids, proteins), high fat diets, ketogenic diets, hypercaloric diets, and maternal undernutrition. Some older relevant articles were included. The search produced a total of 3590 articles, and 84 studies were included in the qualitative synthesis. Data were extracted and analyzed using charts and the frequency of terms used. We concluded that inadequate nutrient intake during pregnancy was associated with brain defects (diminished cerebral volume, spina bifida, alteration of hypothalamic and hippocampal pathways), an increased risk of abnormal behavior, neuropsychiatric disorders (ASD, ADHD, schizophrenia, anxiety, depression), altered cognition, visual impairment, and motor deficits. Future studies should establish and quantify the benefits of maternal nutrition during pregnancy on neurodevelopment and recommend adequate supplementation.

3 June 2024 in Parkinsonism & Related Disorders
Verified
Journal Article
Closed access
DANNA GARCIA-GUAQUETADANNA GARCIA-GUAQUETA
DANNA GARCIA-GUAQUETA
YSYehkyoung C. Stephens
Yehkyoung C. Stephens
FAFarwa Ali
Farwa Ali
RURene L. Utianski
Rene L. Utianski
JDJoseph R. Duffy
Joseph R. Duffy
KJKeith A. Josephs
Keith A. Josephs

2 November 2024 in The Journal of Allergy and Clinical Immunology: In Practice
Verified
Journal Article
Closed access
NPNisha B. Patel
Nisha B. Patel
GCGabriel Cojuc-Konigsberg
Gabriel Cojuc-Konigsberg
DANNA GARCIA-GUAQUETADANNA GARCIA-GUAQUETA
DANNA GARCIA-GUAQUETA
DSDivya Shah
Divya Shah
DBDarshana Balasubramaniam
Darshana Balasubramaniam
SCSergio E. Chiarella
Sergio E. Chiarella

3 September 2024 in Journal of Child Neurology
Verified
Journal Article
Closed access
APAlexia M. Perez
Alexia M. Perez
DANNA GARCIA-GUAQUETADANNA GARCIA-GUAQUETA
DANNA GARCIA-GUAQUETA
BSBindu N. Setty
Bindu N. Setty
CNCaitlin Neri
Caitlin Neri
ATAlcy Torres
Alcy Torres
Introduction: Skull infarction is an uncommonly reported complication of sickle cell disease. We aimed to characterize the clinical and imaging features of skull infarction in pediatric patients with sickle cell disease. Methods: We searched the PubMed database for case reports on skull bone infarction in pediatric patients with sickle cell disease. Out of 67 records retrieved, 15 met inclusion criteria, and a 16th case reported by the senior author was included. We extracted and analyzed clinical and imaging data. Results: The most common symptom at onset was headache (88%). Bilateral skull infarction (50%) and parietal bone involvement (82%) were frequent imaging findings. Epidural hematoma developed in 65% of the cases, 30% of patients required drainage, and exchange infusion was reported in 18%. No fatal outcomes were reported. Conclusions: Skull infarction is a potentially severe complication of sickle cell disease presenting unique clinical challenges. Acute headaches should raise suspicion for this condition and may require additional investigation.

27 August 2024 in Neurology
Verified
Journal Article
Closed access
DANNA GARCIA-GUAQUETADANNA GARCIA-GUAQUETA
DANNA GARCIA-GUAQUETA
HBHugo Botha
Hugo Botha
RURene L. Utianski
Rene L. Utianski
JDJoseph R. Duffy
Joseph R. Duffy
HCHeather Clark
Heather Clark
KJKeith A. Josephs
Keith A. Josephs
Nonverbal oral apraxia (NVOA) is the inability to plan, sequence, and execute voluntary oromotor movements in the absence of weakness. In the context of neurodegenerative disease, it remains unclear whether it is linked to a specific underlying pathologic, clinical, or neuroimaging finding. Thus, we aimed to assess the clinicopathologic and neuroimaging associations of NVOA. We conducted a retrospective study of autopsy-confirmed patients previously assessed through an NVOA evaluation tool with a previously published cutpoint to screen for NVOA. We compared demographic and clinical characteristics and postmortem pathology between those who developed NVOA and those who did not. We also compared clinicopathologic characteristics in mild vs greater than mild NVOA and early vs late-emerging NVOA. SPM12 was used to assess patterns of gray matter loss in NVOA vs non-NVOA with age and sex included as covariates. A total of 104 patients (median age at symptom onset 63 years, 43% female) were included in the study. 63 (60.6%) developed NVOA. NVOA appeared at a median of 4.3 years from symptom onset. 29% developed NVOA within the first 3 years. Primary progressive apraxia of speech and the nonfluent variant of primary progressive aphasia were the most common baseline diagnoses in the NVOA group while progressive supranuclear palsy (PSP) syndrome and logopenic progressive aphasia (LPA) were the most common in patients without NVOA. Atrophy of the left lateral and medial posterior frontal cortex was related to NVOA. The most common pathologies associated with NVOA were PSP (36.5%) and corticobasal degeneration (CBD) (33.3%). In patients without NVOA, PSP (26.8%) and other pathologies (26.8%) were the most frequent. 11% of patients with NVOA had persistently mild NVOA and were more likely to have baseline diagnoses of LPA, PSP syndrome, or semantic dementia. The most frequent pathologies in this group were Alzheimer disease and PSP. The pathologic associations of greater than mild NVOA were CBD and PSP. NVOA is present in several clinical syndromes. It is most associated with PSP and CBD. NVOA is a manifestation of left lateral and medial posterior frontal cortex damage rather than a particular pathology.